Free Trial

Centessa Pharmaceuticals (CNTA) SEC Filings & 10K Form

Centessa Pharmaceuticals logo
$17.01 -0.52 (-2.97%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$17.47 +0.46 (+2.73%)
As of 08/22/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Centessa Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/15/2025
5:13 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
8:01 AM
Adage Capital Management, L.P. (Filed by)
Centessa Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/12/2025
6:13 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2025
6:07 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2025
4:00 PM
Accardi Mario Alberto (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
4:00 PM
Accardi Mario Alberto (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
5:24 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:39 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:15 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
6:42 PM
Accardi Mario Alberto (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
6:43 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
6:44 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:06 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2025
12:54 PM
Accardi Mario Alberto (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
3:10 PM
Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:11 PM
Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:11 PM
Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:12 PM
Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:13 PM
Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:13 PM
Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:58 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
7:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
8:15 AM
Centessa Pharmaceuticals (Filer)
Form DEFA14A
05/27/2025
5:31 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:44 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:19 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:49 PM
Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:18 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
8:03 AM
Adage Capital Management, L.P. (Filed by)
Centessa Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/06/2025
8:00 AM
Centessa Pharmaceuticals (Filer)
Centessa Pharmaceuticals (Filer)
Form DEF 14A
05/06/2025
8:03 AM
Centessa Pharmaceuticals (Filer)
Form ARS
05/02/2025
3:17 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
3:58 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:09 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2025
7:20 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
4:43 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
3:46 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2025
3:59 PM
Centessa Pharmaceuticals (Filer)
Form PRE 14A
04/21/2025
3:14 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
6:31 AM
Centessa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel

Watch the National Emergency broadcast here
03/24/2025
6:11 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:53 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:08 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:47 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:47 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:45 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:25 PM
Centessa Pharmaceuticals (Subject)
CHAO DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
4:45 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:59 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:33 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:14 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:08 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
3:04 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
3:16 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:00 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:30 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:33 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:28 PM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
5:10 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:22 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:18 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
4:09 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:10 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:11 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:03 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:03 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:33 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:43 PM
Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:16 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
6:19 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
10/25/2024
3:10 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:27 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:15 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q/A
09/27/2024
3:15 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:01 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:55 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTA) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners